OTCMKTS:VYCO Vycor Medical (VYCO) Stock Price, News & Analysis → Protect Your Bank Account from China (From Behind the Markets) (Ad) Free VYCO Stock Alerts $0.09 0.00 (0.00%) (As of 06/17/2024 ET) Add Compare Share Share Today's Range$0.09▼$0.0950-Day Range$0.08▼$0.1352-Week Range$0.04▼$0.13VolumeN/AAverage Volume11,136 shsMarket Capitalization$2.94 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartFinancialsSEC FilingsShort InterestStock AnalysisChartFinancialsSEC FilingsShort Interest Get Vycor Medical alerts: Email Address Ad Behind the MarketsWill this AI Micro-Cap be Bigger than NVIDIA?With NVIDIA flying high, everyone is looking for the next breakout AI stock. But right now... There's only ONE AI stock you should be watching.Get the full story here >>> About Vycor Medical Stock (OTCMKTS:VYCO)Vycor Medical, Inc. designs, develops, and markets neurological medical devices and therapies in the United States and Europe. It operates through two segments: Vycor Medical and NovaVision. The Vycor Medical segment provides devices for neurosurgery comprising ViewSite Brain Access System, a retraction and access system for brain and spine surgeries. The NovaVision segment offers non-invasive computer-based rehabilitation targeted at people who have impaired vision as a result of stroke or other brain injury. It has a license agreement which grants for the license to provide NovaVision's products and therapies to patients and professionals in Germany, Austria and Switzerland. It primarily serves hospitals and medical professionals. Vycor Medical, Inc. was founded in 2005 and is headquartered in Boca Raton, Florida. Vycor Medical, Inc. is a subsidiary of Fountainhead Capital Management Limited.Read More VYCO Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart VYCO Stock News HeadlinesJune 14, 2024 | americanbankingnews.comVycor Medical, Inc. (OTCMKTS:VYCO) Sees Significant Increase in Short InterestJanuary 7, 2023 | finance.yahoo.comVycor Medical, Inc. (VYCO)November 1, 2022 | health.usnews.comMedical Review BoardSeptember 8, 2022 | reuters.comVycor Medical IncDecember 17, 2021 | nasdaq.comVycor Medical Inc (VYCO)See More Headlines Receive VYCO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Vycor Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/17/2020Today6/18/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolOTCMKTS:VYCO Previous SymbolOTCMKTS:VYCO CUSIP92921M203 CIK1424768 Webwww.vycormedical.com Phone(561) 558-2000Fax631-794-2444Employees8Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$1.46 million Price / Sales2.01 Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares32,630,000Free FloatN/AMarket Cap$2.94 million OptionableNot Optionable Beta0.48 These 7 Stocks Will Be Magnificent in 2024With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.Get This Free Report Key ExecutivesMr. Peter C. Zachariou (Age 62)CEO & Director Mr. David Marc Cantor (Age 58)President & Director Mr. Adrian Christopher Liddell (Age 65)Chairman & CFO Key CompetitorsSeaStar MedicalNASDAQ:ICUSTRATA Skin SciencesNASDAQ:SSKNPAVmedNASDAQ:PAVMBiotricityNASDAQ:BTCYNeuroMetrixNASDAQ:NUROView All Competitors VYCO Stock Analysis - Frequently Asked Questions How have VYCO shares performed in 2024? Vycor Medical's stock was trading at $0.0772 on January 1st, 2024. Since then, VYCO shares have increased by 16.6% and is now trading at $0.09. View the best growth stocks for 2024 here. Are investors shorting Vycor Medical? Vycor Medical saw a increase in short interest in the month of May. As of May 31st, there was short interest totaling 1,500 shares, an increase of 114.3% from the May 15th total of 700 shares. Based on an average daily volume of 6,900 shares, the short-interest ratio is currently 0.2 days. View Vycor Medical's Short Interest. How were Vycor Medical's earnings last quarter? Vycor Medical, Inc. (OTCMKTS:VYCO) released its quarterly earnings results on Monday, August, 17th. The medical device company reported ($0.01) earnings per share (EPS) for the quarter. The medical device company had revenue of $0.24 million for the quarter. What other stocks do shareholders of Vycor Medical own? Based on aggregate information from My MarketBeat watchlists, some companies that other Vycor Medical investors own include Fly Leasing (FLY), Idera Pharmaceuticals (IDRA), ACADIA Pharmaceuticals (ACAD), Bellicum Pharmaceuticals (BLCM), Drone Aviation (DRNE), Intercept Pharmaceuticals (ICPT), Paratek Pharmaceuticals (PRTK) and Shopify (SHOP). How do I buy shares of Vycor Medical? Shares of VYCO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:VYCO) was last updated on 6/18/2024 by MarketBeat.com Staff From Our PartnersBigger Than NVIDIA?With NVIDIA flying high, everyone is looking for the next breakout stock. But right now... There's only ...Behind the Markets | SponsoredBeta testers blew this thing upThis AI trading tool is probably unlike anything you've ever seen before… It scans the entire market and fi...Prosper Trading Academy | SponsoredRadical change coming — do this NOW to protect yourselfI recently uncovered a way the government could use the next crisis as a pretext to gain more control … and ra...Weiss Ratings | SponsoredUnexpected twist to Trump’s trialUnexpected Twist to Trump's Trial Most folks sense there's more to the Trump trial than meets the eye. B...Stansberry Research | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...Crypto 101 Media | SponsoredElon Musk: THIS will be bigger than TeslaIf you missed out on crypto, this could be your second chance. The AI “wealth window” is opening now, but you ...Paradigm Press | SponsoredMissed NVDA? Buy this AI stock NOWAfter Nvidia's record-breaking earnings surge, Wall Street is now selling the stock at the fastest pace in sev...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vycor Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vycor Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.